At a Forum Europe Conference in Brussels, the pharmaceutical industry discussed with NGOs and EU decision makers what the Union can do to improve access to health care in the developing countries.
The following issues were raised in three main sessions:
- the influence of WTO’s TRIPS (Trade-Related Aspects of Intellectual Property Rights) regime on global access to medicines;
- the lack of public health infrastructure and health care systems in the developing countries;
- the need to improve local infrastructures, incentivise research and development, and promote education;
- the positive role of public-private partnerships.